Effect of an Emergency Department Care Bundle on 30-Day Hospital Discharge and Survival Among Elderly Patients With Acute Heart Failure: The ELISABETH Randomized Clinical Trial
- PMID: 33201202
- PMCID: PMC7672513
- DOI: 10.1001/jama.2020.19378
Effect of an Emergency Department Care Bundle on 30-Day Hospital Discharge and Survival Among Elderly Patients With Acute Heart Failure: The ELISABETH Randomized Clinical Trial
Abstract
Importance: Clinical guidelines for the early management of acute heart failure in the emergency department (ED) setting are based on only moderate levels of evidence, with subsequent low adherence to these guidelines.
Objective: To test the effect of an early guideline-recommended care bundle on short-term prognosis in older patients with acute heart failure in the ED.
Design, setting, and participants: Stepped-wedge cluster randomized trial in 15 EDs in France of 503 patients 75 years and older with a diagnosis of acute heart failure in the ED from December 2018 to September 2019 and followed up for 30 days until October 2019.
Interventions: A care bundle that included early intravenous nitrate boluses; management of precipitating factors, such as acute coronary syndrome, infection, or atrial fibrillation; and moderate dose of intravenous diuretics (n = 200). In the control group, patient care was left to the discretion of the treating emergency physician (n = 303). Each center was randomized to the order in which they switched to the "intervention period." After the initial 4-week control period for all centers, 1 center entered in the intervention period every 2 weeks.
Main outcomes and measures: The primary end point was the number of days alive and out of hospital at 30 days. Secondary outcomes included 30-day all-cause mortality, 30-day cardiovascular mortality, unscheduled readmission, length of hospital stay, and kidney impairment.
Results: Among 503 patients who were randomized (median age, 87 years; 298 [59%] women), 502 were analyzed. In the intervention group, patients received a median (interquartile range) of 27.0 (9-54) mg of intravenous nitrates in the first 4 hours vs 4.0 (2.0-6.0) mg in the control group (adjusted difference, 23.8 [95% CI, 13.5-34.1]). There was a significantly higher percentage of patients in the intervention group treated for their precipitating factors than in the control group (58.8% vs 31.9%; adjusted difference, 31.1% [95% CI, 14.3%-47.9%]). There was no statistically significant difference in the primary end point of the number of days alive and out of hospital at 30 days (median [interquartile range], 19 [0- 24] d in both groups; adjusted difference, -1.9 [95% CI, -6.6 to 2.8]; adjusted ratio, 0.88 [95% CI, 0.64-1.21]). At 30 days, there was no significant difference between the intervention and control groups in mortality (8.0% vs 9.7%; adjusted difference, 4.1% [95% CI, -17.2% to 25.3%]), cardiovascular mortality (5.0% vs 7.4%; adjusted difference, 2.1% [95% CI, -15.5% to 19.8%]), unscheduled readmission (14.3% vs 15.7%; adjusted difference, -1.3% [95% CI, -26.3% to 23.7%]), median length of hospital stay (8 d in both groups; adjusted difference, 2.5 [95% CI, -0.9 to 5.8]), and kidney impairment (1% in both groups).
Conclusions and relevance: Among older patients with acute heart failure, use of a guideline-based comprehensive care bundle in the ED compared with usual care did not result in a statistically significant difference in the number of days alive and out of the hospital at 30 days. Further research is needed to identify effective treatments for acute heart failure in older patients.
Trial registration: ClinicalTrials.gov Identifier: NCT03683212.
Conflict of interest statement
Figures


Comment in
-
Effect of Emergency Department Care Bundle on Elderly Patients With Acute Heart Failure.JAMA. 2021 Mar 9;325(10):1007. doi: 10.1001/jama.2020.27291. JAMA. 2021. PMID: 33687459 No abstract available.
Similar articles
-
Early and comprehensive care bundle in the elderly for acute heart failure in the emergency department: study protocol of the ELISABETH stepped-wedge cluster randomized trial.Trials. 2019 Jan 31;20(1):95. doi: 10.1186/s13063-019-3188-8. Trials. 2019. PMID: 30704508 Free PMC article.
-
Association of early doses of diuretics and nitrates in acute heart failure with 30 days outcomes: ancillary analysis of ELISABETH study.Eur J Emerg Med. 2025 Feb 1;32(1):46-51. doi: 10.1097/MEJ.0000000000001165. Epub 2024 Jul 31. Eur J Emerg Med. 2025. PMID: 39082268 Clinical Trial.
-
Effect of a Self-care Intervention on 90-Day Outcomes in Patients With Acute Heart Failure Discharged From the Emergency Department: A Randomized Clinical Trial.JAMA Cardiol. 2021 Feb 1;6(2):200-208. doi: 10.1001/jamacardio.2020.5763. JAMA Cardiol. 2021. PMID: 33206126 Free PMC article. Clinical Trial.
-
Continuous infusion vs. intermittent bolus injection of furosemide in acute decompensated heart failure: systematic review and meta-analysis of randomised controlled trials.Anaesthesia. 2018 Feb;73(2):238-247. doi: 10.1111/anae.14038. Epub 2017 Sep 22. Anaesthesia. 2018. PMID: 28940440
-
[Early source control of infection in patients seen in the emergency department: a systematic review].Rev Esp Quimioter. 2024 Aug;37(4):323-333. doi: 10.37201/req/027.2024. Epub 2024 May 14. Rev Esp Quimioter. 2024. PMID: 38742536 Free PMC article. Spanish.
Cited by
-
Evolving therapeutic strategies for patients hospitalized with new or worsening heart failure across the spectrum of left ventricular ejection fraction.Clin Cardiol. 2022 Jun;45 Suppl 1(Suppl 1):S40-S51. doi: 10.1002/clc.23849. Clin Cardiol. 2022. PMID: 35789014 Free PMC article. Review.
-
Changes in Blood Eosinophil Counts Predict the Death of Patients With Myocardial Infarction After Hospital Discharge.J Am Heart Assoc. 2025 Jan 7;14(1):e035383. doi: 10.1161/JAHA.124.035383. Epub 2024 Dec 20. J Am Heart Assoc. 2025. PMID: 39704243 Free PMC article.
-
Vasodilators for acute heart failure-A protocol for a systematic review of randomized clinical trials with meta-analysis and Trial Sequential Analysis.Acta Anaesthesiol Scand. 2022 Oct;66(9):1156-1164. doi: 10.1111/aas.14130. Epub 2022 Aug 23. Acta Anaesthesiol Scand. 2022. PMID: 36054782 Free PMC article.
-
Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19: a randomised double-blinded placebo-controlled trial.Eur Respir J. 2022 Jan 6;59(1):2100752. doi: 10.1183/13993003.00752-2021. Print 2022 Jan. Eur Respir J. 2022. PMID: 34083403 Free PMC article. Clinical Trial.
-
Hypertensive acute heart failure: a critical perspective on definition, epidemiology, pathophysiology, and prognosis-a narrative review: a joint session with the Romanian Society of Cardiology (part II).Heart Fail Rev. 2025 Sep 2. doi: 10.1007/s10741-025-10551-w. Online ahead of print. Heart Fail Rev. 2025. PMID: 40892348 Review.
References
-
- Teixeira A, Parenica J, Park JJ, et al. ; GREAT (Global Research on Acute Conditions Team) Network . Clinical presentation and outcome by age categories in acute heart failure: results from an international observational cohort. Eur J Heart Fail. 2015;17(11):1114-1123. doi:10.1002/ejhf.330 - DOI - PubMed
-
- McMurray JJV, Adamopoulos S, Anker SD, et al. ; ESC Committee for Practice Guidelines . ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33(14):1787-1847. doi:10.1093/eurheartj/ehs104 - DOI - PubMed
-
- Mebazaa A, Yilmaz MB, Levy P, et al. . Recommendations on pre-hospital & early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine. Eur J Heart Fail. 2015;17(6):544-558. doi:10.1002/ejhf.289 - DOI - PubMed